Page last updated: 2024-10-15

cupferron

Description

cupferron: superoxide dismutase inhibitor; RN given refers to parent cpd; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID135465076
SCHEMBL ID52291
MeSH IDM0099701

Synonyms (35)

Synonym
ammonium 2-oxo-1-phenylhydrazinolate
n-nitroso-n-phenylhydroxylamine ammonium salt
nci-c03258
cupferron
n-nitrosophenylhydroxylamine ammonium salt
NCGC00091873-01
n-nitroso-n-phenylhydroxylamine, ammonium salt
ccris 184
ai3-63016
ammonium nitroso-beta-phenylhydroxylamine
hsdb 4109
nsc 112124
cupferon [czech]
kupferron [czech]
einecs 205-183-2
n-nitrosofenylhydroxylamin amonny [czech]
ammonium-n-nitrosophenylhydroxylamine
n-nitrosophenylhydroxylamin ammonium salz [german]
dtxcid90352
dtxsid1020352 ,
cas-135-20-6
tox21_302952
NCGC00256368-01
NCGC00259044-01
tox21_201493
benzenamine, n-hydroxy-n-nitroso-, ammonium salt (1:1)
v66qk963ed ,
unii-v66qk963ed
JC10087
AKOS015890386
SCHEMBL52291
cupferron [hsdb]
cupferron [mi]
n-hydroxy-n-nitrosobenzenamine ammonium salt (1:1)
AMY22842

Treatment

ExcerptReference
"Cupferron-treated bacteria showed increased susceptibility to biofilm production, oxidative stress, and impaired bacterial motility in a dose-dependent manner."( Cupferron impairs the growth and virulence of Escherichia coli clinical isolates.
De Filippis, A; Dell'Annunziata, F; Foglia, F; Folliero, V; Franci, G; Galdiero, M; Marca, RD; Palma, F; Zannella, C, 2023
)
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (44)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, TYROSYL-DNA PHOSPHODIESTERASEHomo sapiens (human)Potency44.66840.004023.8416100.0000AID485290
Chain A, HADH2 proteinHomo sapiens (human)Potency25.11890.025120.237639.8107AID886
Chain B, HADH2 proteinHomo sapiens (human)Potency25.11890.025120.237639.8107AID886
LuciferasePhotinus pyralis (common eastern firefly)Potency28.85050.007215.758889.3584AID1224835
RAR-related orphan receptor gammaMus musculus (house mouse)Potency34.60960.006038.004119,952.5996AID1159521; AID1159523
AR proteinHomo sapiens (human)Potency51.48290.000221.22318,912.5098AID1259243; AID743054
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency10.00000.011212.4002100.0000AID1030
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency38.72520.001022.650876.6163AID1224838; AID1224839; AID1224893
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency34.31130.003041.611522,387.1992AID1159552; AID1159553; AID1159555
retinoid X nuclear receptor alphaHomo sapiens (human)Potency48.52920.000817.505159.3239AID1159527
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency50.82480.001530.607315,848.9004AID1224841; AID1259401; AID1259403
farnesoid X nuclear receptorHomo sapiens (human)Potency39.81070.375827.485161.6524AID588526
pregnane X nuclear receptorHomo sapiens (human)Potency47.47390.005428.02631,258.9301AID1346982
estrogen nuclear receptor alphaHomo sapiens (human)Potency39.49740.000229.305416,493.5996AID1259244; AID1259248; AID1259383; AID588513; AID743069; AID743075; AID743079; AID743080; AID743091
peroxisome proliferator-activated receptor deltaHomo sapiens (human)Potency28.18380.001024.504861.6448AID588534
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency70.79460.001019.414170.9645AID588537
aryl hydrocarbon receptorHomo sapiens (human)Potency52.45990.000723.06741,258.9301AID743085; AID743122
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency50.23660.001723.839378.1014AID743083
thyroid stimulating hormone receptorHomo sapiens (human)Potency67.96230.001628.015177.1139AID1224843
v-jun sarcoma virus 17 oncogene homolog (avian)Homo sapiens (human)Potency59.38590.057821.109761.2679AID1159526; AID1159528
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1Homo sapiens (human)Potency12.58930.001815.663839.8107AID894
thyroid hormone receptor beta isoform aHomo sapiens (human)Potency0.14130.010039.53711,122.0200AID588547
histone deacetylase 9 isoform 3Homo sapiens (human)Potency32.64460.037617.082361.1927AID1259364; AID1259388
heat shock protein beta-1Homo sapiens (human)Potency56.06390.042027.378961.6448AID743210; AID743228
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency45.99550.000627.21521,122.0200AID651741; AID720636; AID743219
cytochrome P450 3A4 isoform 1Homo sapiens (human)Potency31.62280.031610.279239.8107AID884; AID885
Gamma-aminobutyric acid receptor subunit piRattus norvegicus (Norway rat)Potency31.62281.000012.224831.6228AID885
Voltage-dependent calcium channel gamma-2 subunitMus musculus (house mouse)Potency30.63790.001557.789015,848.9004AID1259244
Gamma-aminobutyric acid receptor subunit beta-1Rattus norvegicus (Norway rat)Potency31.62281.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit deltaRattus norvegicus (Norway rat)Potency31.62281.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)Potency31.62281.000012.224831.6228AID885
Glutamate receptor 2Rattus norvegicus (Norway rat)Potency30.63790.001551.739315,848.9004AID1259244
Gamma-aminobutyric acid receptor subunit alpha-5Rattus norvegicus (Norway rat)Potency31.62281.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-3Rattus norvegicus (Norway rat)Potency31.62281.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-1Rattus norvegicus (Norway rat)Potency31.62281.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-2Rattus norvegicus (Norway rat)Potency31.62281.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-4Rattus norvegicus (Norway rat)Potency31.62281.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-3Rattus norvegicus (Norway rat)Potency31.62281.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-6Rattus norvegicus (Norway rat)Potency31.62281.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)Potency31.62281.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-3Rattus norvegicus (Norway rat)Potency31.62281.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)Potency31.62281.000012.224831.6228AID885
GABA theta subunitRattus norvegicus (Norway rat)Potency31.62281.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit epsilonRattus norvegicus (Norway rat)Potency31.62281.000012.224831.6228AID885
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Ceullar Components (1)

Processvia Protein(s)Taxonomy
plasma membraneGamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)
plasma membraneGlutamate receptor 2Rattus norvegicus (Norway rat)
plasma membraneGamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)
plasma membraneGamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)
[Information is prepared from geneontology information from the June-17-2024 release]

Research

Studies (33)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (24.24)18.7374
1990's3 (9.09)18.2507
2000's9 (27.27)29.6817
2010's10 (30.30)24.3611
2020's3 (9.09)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other35 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]